Marker Therapeutics Other Current Borrowings (Quarterly) Analysis

Marker Therapeutics, Inc. (MRKR)

1.92 +0.11 (+6.08%) USD | NASDAQ | Jan 20, 11:31

View Other Current Borrowings (Quarterly) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Borrowings (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Borrowings (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Borrowings (Quarterly) Benchmarks

Start Trial

Viridian Therapeutics, Inc.	Upgrade
ADMA Biologics, Inc.	--
Kiniksa Pharmaceuticals International Plc	--
Neurocrine Biosciences, Inc.	--
AIM ImmunoTech, Inc.	Upgrade